BioSpace News Archive

Verrica Pharmaceuticals Inc. announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the 42nd Annual Cowen Virtual Healthcare Conference on Wednesday, March 9, 2022, at 11:10 a.m. ET.

JAMA Network Open has published “Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment,”1 which evaluated the more than 8,000 patients recruited to participate in the REDUCE-IT® clinical trial.

Morphic Therapeutic, a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, reported corporate highlights and financial results for the full year 2021.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Tuesday, March 1, 2022 at 8:30 AM ET to discuss results for the fourth quarter and year-end 2021 and provide a business outlook for 2022.

Radius Health, Inc., reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided key business and financial objectives for 2022.

Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases today announced the submission of a Marketing Authorization Application (MAA) via centralized procedure to the European Medicines Agency (EMA) for pegunigalsidase alfa (PRX–102),

GT Biopharma, Inc. announced today that GT Biopharma will be participating in the following upcoming medical conferences.

Motus GI Holdings, Inc. announced that the Company received written notification from the Listing Qualification Department of The NASDAQ Capital Market granting the Company’s request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement under Nasdaq Listing Rule 5550.

Conformis, Inc. announced that the Orthopaedic Data Evaluation Panel in the United Kingdom awarded the Conformis iTotal® CR knee replacement system a “7A” rating.

Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42nd Annual Cowen Healthcare Conference on Wednesday, March 9th at 2:10 pm Eastern time / 11:10 am Pacific Time.